Purchase Order 75N95D25P00029

This federal contract award to Scantox Neuro GMBH, a for-profit organization based in Austria, is for $249,000.00 to conduct tolerability studies of candidate Alzheimer's disease (AD) drugs and evaluate the efficacy of poly(L-lysine succinylated)-hydroxychloroquine (PLS-HCQ) in a transgenic AD mouse model. The award is part of the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and Experimental Validation of Candidate Alzheimer's Disease Treatments Identified by Multi-Omics Analyses...

This is a $63,756 firm fixed-price purchase order awarded by the National Institute on Aging (NIA) to Goteborgs Universitet, a foreign educational institution and state-controlled institution of higher learning located in Gothenburg, Sweden. The contract is for testing associations between whole blood hydroxychloroquine (HCQ) levels and blood biomarkers of neurodegeneration. Specifically, the contractor will perform assays on 460 plasma samples from lupus patients to measure 120 biomarkers...

This is a firm fixed-price delivery order contract awarded by the National Institute on Aging (NIA), a civilian federal agency, to Scantox Neuro GMBH, a for-profit organization based in Austria. The contract, valued at $858,106.08, is for the experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. This work supports ongoing NIA research initiatives such as the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) and PREVENT-AD studies....

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of hydroxychloroquine 200 mg tablets in 100-count packages. The contract has a ceiling value of $1,020.00 and a completion date of December 7, 2022. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...

<p>The U.S. National Institute on Aging (NIA), a civilian federal agency, has awarded a $20,000.00 firm fixed price purchase order contract to Voros Innovation &amp; Business Services PTY LTD, a for-profit organization located in Australia. The contract is for laboratory services related to molecular modeling analysis, and has a period of performance through February 21, 2025. The contract is not set aside for any specific business type.</p>

This is a $1,485,008.40, firm-fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri). The contract is for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities to support a medicinal chemistry discovery program focused on identifying molecules that bind the KIAA0203 protein, which could potentially lead to the development of a...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $203,298.48 firm fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, to provide OLINK EXPLORE HT REAGENT KITS. The contract has a completion date of April 24, 2024 and does not have a set-aside designation. The original pre-solicitation notice indicates that the National Institutes of Health National Institute on Drug Abuse is...

<p>The National Institute on Aging, a civilian federal agency, awarded a $17,500.00 Firm Fixed Price Purchase Order to Alamar Biosciences, Inc. to provide laboratory and testing services for the NULISASEQ CNS Disease Panel service. The award has an ultimate completion date of August 11, 2024. The contract does not have a set-aside designation.</p>

<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>

The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded Olink Proteomics Inc. a $74,130.04 firm fixed price purchase order to deliver EXPLORE 3072 REAGENT KITS. Performance will take place in Isveç, Turkey from July 25, 2023 through September 25, 2023. The National Institute on Aging supports biomedical research on the aging process and age-related diseases to promote the health and well-being of older adults. This purchase order for reagent...